Intellegens
Intellegens commercializes Alchemite™, a proprietary Cambridge-developed deep learning platform that builds predictive models from sparse, noisy R&D data, serving enterprise customers in chemicals, materials, life sciences, manufacturing, and FMCG through SaaS subscriptions and professional services.
- Company typePrivate
- Founded2017
- HeadquartersCambridge, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Intellegens does
Intellegens Limited is a Cambridge, UK-based private company founded in 2017 that commercializes Alchemite™, a proprietary deep learning platform originating from research at the University of Cambridge. Alchemite is purpose-built to build predictive models from sparse, noisy, and incomplete experimental and process data — the characteristic data profile of industrial R&D in chemicals, materials, formulations, manufacturing, and life sciences — and to support adaptive Design of Experiments, formulation optimization, explainable R&D analytics, and emerging agentic workflows. The platform is delivered through a browser-based Analytics interface and an Architect edition with API access, with vertical modules for DOE, Formulations, R&D Insights, and Oligonucleotide Manufacturing.
The company operates a hybrid go-to-market combining product-led free trials and demo requests with enterprise field sales targeting large industrial customers. Revenue is generated through quote-based annual SaaS subscriptions of the Alchemite Suite and a parallel professional services stream branded Alchemite Success, which includes pilot project support, training via Alchemite Academy, and custom implementation. Pricing is not publicly disclosed. Customer segments span chemicals, materials, life sciences (including oligonucleotide therapeutics), FMCG and foods, and additive manufacturing, with named logos including NASA, Boeing, Rolls-Royce, Johnson Matthey, Genentech, Novartis, Voestalpine, FUCHS, Tata Steel, Godrej Aerospace, Lawrence Livermore National Laboratory, and AMRC. Marketing is delivered through technical content (case studies, white papers, publications), webinars, industry conferences, the Alchemite Focus Group community, and the academic programme.
Intellegens is bootstrapped — its disclosed funding consists entirely of Innovate UK grants, most notably a £1.6 million award in August 2023 for oligonucleotide therapeutics manufacturing — with no disclosed venture capital or private equity investment. The company holds ISO 27001 certification, employs 11-50 staff, and was recognised with ASME AM Tech Forum Best in Class Software and Startup awards in 2021 and selection for the ATI Boeing Accelerator in 2019.
Intellegens firmographics
Firmographics- Name
- Intellegens
- Legal name
- Intellegens Limited
- Website
- https://intellegens.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Intellegens commercializes Alchemite™, a proprietary Cambridge-developed deep learning platform that builds predictive models from sparse, noisy R&D data, serving enterprise customers in chemicals, materials, life sciences, manufacturing, and FMCG through SaaS subscriptions and professional services.
- Ownership category
- akta.pro rank
Intellegens industry classification
Industry- Product category
- Machine Learning Software for R&D
- NAICS
- Software Publishers (5132), Computer Systems Design and Related Services (54151), Scientific Research and Development Services (5417), Computer Training (611420)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Model Development & Training Platforms (AutoML, Notebooks, Feature Stores) (HDAEANAB)
- akta.pro secondary industries
- AI/ML Solution Integration & MLOps Enablement (BPAEAAAJ), Corporate Learning & Training Content Development (EDAGAKAC)
Keywords
Where Intellegens is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Intellegens business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Software Licensing (Alchemite Suite): SaaS subscription-based licensing of the Alchemite machine learning software platform. Customers access the software through a web-based interface with tiered options for different team sizes and use cases. The model includes free trials for evaluation and professional services for onboarding.
- Professional Services: Consulting and technical support services including Alchemite Success team engagement, pilot project support, training (Alchemite Academy), and custom implementation assistance to help organizations maximize value from the platform.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise subscription with custom pricing based on organization size and deployment scope |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels8 records
Intellegens product offering
Product offeringCore offering
Intellegens develops and licenses the Alchemite™ Suite, an enterprise machine learning software platform that builds predictive models from sparse, noisy, and incomplete experimental data for R&D teams in chemicals, materials, FMCG, life sciences, and manufacturing. The platform includes specialized modules for Design of Experiments, formulations, R&D insights, and oligonucleotide manufacturing, delivered as an annual subscription with quote-based pricing plus optional professional services.
Product overview
Intellegens offers the Alchemite™ Suite as its core product platform, a unified machine learning solution designed for R&D teams in chemicals, materials, FMCG, life sciences, and manufacturing. The platform employs unique deep learning technology developed at the University of Cambridge that works with sparse, noisy experimental data where conventional machine learning fails. The product architecture includes the Alchemite™ Analytics browser-based platform for scientists and engineers, the Alchemite™ Architect edition with API access for data scientists, and specialized modules including Alchemite™ for DOE (Design of Experiments), Alchemite™ for Formulations, Alchemite™ for R&D Insights, and Alchemite™ for Oligonucleotide Manufacturing. Supporting offerings include the Alchemite™ Academic Programme, Alchemite™ Academy for training, and Alchemite™ Success Services for consultancy support. Intellegens also offers the Ichnite™ software product for data management. The platform enables adaptive experimental design that reduces experimental workloads by 50-80% while finding solutions missed by traditional DOE methods.
Differentiator
Problem solved
Functional benefit
Brands
- Alchemite™ Suite: AI-powered machine learning software platform for design of experiments, formulations, and R&D insights
- Alchemite™ for DOE
- Alchemite™ for Formulations
- Alchemite™ for R&D Insights
- Alchemite™ for Oligonucleotides
- Ichnite™
Products and services
- Alchemite™ Suite Unified machine learning platform applying deep learning for sparse, noisy data to optimize products and processes across chemicals, materials, FMCG, life sciences, and manufacturing sectors.
- Alchemite™ for DOE Design of Experiments module that cuts 50-80% from experimental workloads while finding solutions that traditional DOE methods would miss, enabling faster, fewer, better experiments for R&D teams.
- Alchemite™ for Formulations Formulation development module for chemicals, materials, and consumer products that accelerates innovation by rapidly optimizing formulations, materials, and chemicals.
- Alchemite™ for R&D Insights Analytics and insights module that unlocks hidden value in experimental and process data, empowering data-driven decision making through explainable AI tools.
- Alchemite™ for Oligonucleotide Manufacturing Specialized module applying AI and machine learning to accelerate process development for oligonucleotide therapeutics manufacturing, improving productivity and quality control.
- Alchemite™ Analytics Browser-based web user interface platform for scientists and engineers to apply Alchemite through tailored workflows for formulation, materials, chemical, and process design.
- Alchemite™ Architect Platform edition providing API access for data scientists to integrate the Alchemite algorithm with their own scripts and tools for integration with existing workflows.
- Alchemite™ Success Services Consultancy and support services to help customers successfully apply Alchemite to their R&D challenges, including project guidance and domain expertise.
- Alchemite™ Academic Programme Program providing academic researchers access to Alchemite machine learning software for research and educational purposes.
- Alchemite™ Academy Training initiative that upskills researchers in machine learning applications for R&D, providing educational resources alongside the software platform.
Quantifiable outcome
- 50-80% reduction in experimental workload
- +5 more outcomes
Companies that use Intellegens
Customer profileNamed customers22 records
Segments6 records
Ideal customer profiles5 records
Intellegens technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature9 records
Intellegens partnerships and signals
Strategic signalPartnerships
17 partnerships are on record, tiered core.
- CPI (Centre for Process Innovation)coreCollaboration on Innovate UK-funded £1.6 million project to enhance manufacturing of oligonucleotide therapeutics using machine learning. CPI provides medicines manufacturing expertise and validation capabilities for Alchemite in biopharmaceutical applications.
- NovartiscoreIndustry partner in the Innovate UK oligonucleotide therapeutics project. Novartis contributes pharmaceutical manufacturing expertise and real-world data for machine learning model development.
- Silence TherapeuticscoreSpecialized oligonucleotide therapeutics company collaborating on the Innovate UK project to improve manufacturing productivity for these complex biologic drugs.
- Johnson MattheycoreLong-standing collaboration on automotive catalyst design using machine learning. Published peer-reviewed paper on accelerating catalyst product design with Alchemite. Multiple joint publications and ongoing projects.
- NASAcoreNASA Glenn Research Center collaboration to validate Alchemite for materials design. Published NASA Technical Memorandum applying Alchemite to shape memory alloys and heat exchangers. Joint webinar and ongoing technical collaboration.
- BoeingcoreProject MEDAL collaboration with AMRC, Constellium, and GE Additive for data-driven additive manufacturing. Boeing contributes aerospace manufacturing expertise and validates Alchemite for AM process optimization.
- AMRC (University of Sheffield)coreAdvanced Manufacturing Research Centre collaboration on additive manufacturing and composite tooling optimization. AMRC applies Alchemite to aerospace and automotive manufacturing challenges.
- ConstelliumcoreProject MEDAL partner for data-driven additive manufacturing. Constellium provides aluminum expertise and validates Alchemite for aerospace materials development.
- GE AdditivecoreProject MEDAL partner applying machine learning to additive manufacturing process optimization with GE Additive's metal AM systems.
- Rolls-RoycecoreEarly collaboration on nickel-base superalloy design using neural networks. Alchemite designed alloys satisfying 11 physical criteria, validated experimentally.
- Digital CatapultcoreBuild UK-India programme partner supporting cleantech collaboration between UK and Indian industry. Intellegens provides machine learning technology for net zero manufacturing projects.
- Tata SteelcoreBuild UK-India project partner working with Intellegens, Godrej Aerospace, and Johnson Matthey to reduce energy and resource consumption in manufacturing processes.
- Godrej AerospacecoreBuild UK-India project partner applying machine learning to aerospace manufacturing to reduce waste and improve sustainability.
- Henry Royce InstitutecorePartnership to drive materials innovation, combining Intellegens machine learning with Royce's materials research capabilities and network.
- Lawrence Livermore National LaboratorycoreCollaboration on additive manufacturing application of Alchemite machine learning for materials and component design.
- University of CambridgecoreOrigin of Alchemite technology; ongoing research collaboration with Cambridge researchers including CSO Dr Gareth Conduit. Joint publications on concrete design and noise exploitation algorithms.
- AnsyscorePartnership to empower additive manufacturing with material intelligence through machine learning. Ansys Granta and Intellegens combined expertise to improve battery metrics with AI.
Scale indicators6 records
Recent moves3 records
Expansion highlights6 records
Intellegens competitors and assessment
Company assessmentBroad incumbents
- Altair Engineering: Engineering simulation and analytics platform with materials informatics and design optimization capabilities. Competes indirectly through broader CAE and AI-driven design tooling for industrial customers.
- Dassault Systèmes BIOVIA: Enterprise scientific informatics suite spanning lab informatics, materials modeling, and formulation. Competes for the same enterprise budgets as Intellegens but as a broader portfolio offering rather than a specialist ML tool.
- Ansys: Simulation giant with growing AI/ML capabilities for materials, additive manufacturing, and battery design. Already a partner but also a competitor as Ansys Granta integrates data-driven material intelligence features.
Emerging players
- Cosmo Tech: Provider of digital twin technology augmented by AI for industrial process optimization. Comparable where AI is used to optimize complex industrial processes in chemicals and manufacturing.
- Kebotix: Early-stage AI-for-materials company applying machine learning to accelerate discovery of new chemicals and materials. Operates in the same AI-R&D niche as Intellegens but at smaller scale.
Direct peers
- Schrödinger: Computational chemistry and materials simulation platform widely used in drug discovery and materials R&D. Overlaps with Intellegens where predictive modeling drives experimental prioritization for chemistry and formulations customers.
- Citrine Informatics: AI platform purpose-built for materials and chemicals R&D, offering data infrastructure and ML models for formulation and process optimization. Closest direct competitor in the AI-for-materials niche that Intellegens targets.
- Materials Design, Inc. Provider of simulation and modeling tools for materials science, including atomistic and mesoscale methods. Recently announced a partnership with Intellegens, indicating direct overlap in materials R&D tooling.
- Dotmatics: Scientific R&D platform offering ELN, data management, and analytics for chemistry and life sciences labs. Comparable in serving enterprise R&D users integrating ML insights into lab workflows.
- Optibrium: Drug discovery software provider focused on small molecule design and ADMET prediction. Comparable in pharmaceutical R&D use cases and is already a named partner of Intellegens in cheminformatics work.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Intellegens social profiles
Digital presenceIntellegens compliance and trust
Trust signalCompliance1 record
Intellegens financial estimates
Financial estimateRevenue estimate
Valuation estimate
Intellegens leadership team
Management profileNumber of profiles
Profiles7 records
Intellegens funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Intellegens M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Intellegens
What does Intellegens do?
Intellegens develops and licenses the Alchemite™ Suite, an enterprise machine learning software platform that builds predictive models from sparse, noisy, and incomplete experimental data for R&D teams in chemicals, materials, FMCG, life sciences, and manufacturing. The platform includes specialized modules for Design of Experiments, formulations, R&D insights, and oligonucleotide manufacturing, delivered as an annual subscription with quote-based pricing plus optional professional services.
Is Intellegens a public or private company?
Intellegens is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Intellegens founded?
Intellegens was founded in 2017. It employs 11 to 50 people.
Where is Intellegens based?
Intellegens is headquartered in Cambridge, United Kingdom, in the Europe region.
How does Intellegens make money?
Two revenue lines are on record. Software Licensing (Alchemite Suite) is the primary driver. The others are professional Services.
Who are Intellegens's main competitors?
Broad incumbents on record are Altair Engineering, Dassault Systèmes BIOVIA and Ansys. Emerging players are Cosmo Tech and Kebotix. Direct peers are Schrödinger, Citrine Informatics, Materials Design, Inc., Dotmatics and Optibrium.
Does Intellegens have an API?
Yes. Alchemite™ Architect edition provides API access to integrate the Alchemite™ algorithm with users' own scripts and tools. Data scientists can use this to integrate the machine learning capabilities with their existing workflows.
What industry is Intellegens in?
Intellegens's product category is Machine Learning Software for R&D. Its primary akta.pro industry code is HDAEANAB, Model Development & Training Platforms (AutoML, Notebooks, Feature Stores), with a secondary code of BPAEAAAJ, AI/ML Solution Integration & MLOps Enablement. Its NAICS code is 5132 and its SIC code is 7372.